Previous 10 | Next 10 |
24/7 Market News news releases related 24/7 Market News news releases and 24/7 Market News press releases from 01/08/24 07:53:16 on US and Canada Markets.
2024-01-08 07:53:16 ET The following companies are covered in this article, (NASDAQ: CCCC), Merck (NYSE: MRK), (NASDAQ: NEXI), (NASDAQ: SIDU), and (NASDAQ: SYTA) DENVER, Colo, January 8, 2024 ( www.247marketnews.com ) – The Trend is your friend and, when it comes to massive g...
2024-01-08 07:53:16 ET The following companies are covered in this article, (NASDAQ: CCCC), Merck (NYSE: MRK), (NASDAQ: NEXI), (NASDAQ: SIDU), and (NASDAQ: SYTA) DENVER, Colo, January 8, 2024 ( www.247marketnews.com ) – The Trend is your friend and, when it comes to massive g...
2024-01-08 07:53:16 ET The following companies are covered in this article, (NASDAQ: CCCC), Merck (NYSE: MRK), (NASDAQ: NEXI), (NASDAQ: SIDU), and (NASDAQ: SYTA) DENVER, Colo, January 8, 2024 ( www.247marketnews.com ) – The Trend is your friend and, when it comes to massive g...
2024-01-08 07:53:16 ET The following companies are covered in this article, (NASDAQ: CCCC), Merck (NYSE: MRK), (NASDAQ: NEXI), (NASDAQ: SIDU), and (NASDAQ: SYTA) DENVER, Colo, January 8, 2024 ( www.247marketnews.com ) – The Trend is your friend and, when it comes to massive g...
2024-01-08 07:53:16 ET The following companies are covered in this article, (NASDAQ: CCCC), Merck (NYSE: MRK), (NASDAQ: NEXI), (NASDAQ: SIDU), and (NASDAQ: SYTA) DENVER, Colo, January 8, 2024 ( www.247marketnews.com ) – The Trend is your friend and, when it comes to massive g...
2024-01-08 07:21:18 ET DENVER, Colo., Jan. 8, 2023 ( www.247marketnews.com )- Vincerx Pharma, Inc. (NASDAQ: VINC) published, Sunday evening, promising clinical results from a Phase 1 NIH-sponsored study of enitociclib in combination with venetoclax and prednisone for the treatment of re...
2024-01-08 06:56:58 ET DENVER, Colo., Jan. 8, 2023 ( www.247marketnews.com )- Cellectar Biosciences, Inc. (NASDAQ: CLRB) reported, this morning, data from its CLOVER WaM pivotal study, evaluating iopofosine I 131, a potential first-in-class, targeted radiotherapy candidate for the treat...
2024-01-05 12:32:13 ET DENVER, Colo., Jan. 5, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Banzai International Inc (NASDAQ: BNZI), Dermata Therapeutics (NASDAQ: DRMA), Ainos Inc (NASDAQ: AIMD),...
2024-01-05 12:32:13 ET DENVER, Colo., Jan. 5, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Banzai International Inc (NASDAQ: BNZI), Dermata Therapeutics (NASDAQ: DRMA), Ainos Inc (NASDAQ: AIMD),...
2024-01-05 12:32:13 ET DENVER, Colo., Jan. 5, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Banzai International Inc (NASDAQ: BNZI), Dermata Therapeutics (NASDAQ: DRMA), Ainos Inc (NASDAQ: AIMD),...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
20.86%Change Percent:
Predictive Oncology Inc. Company Name:
POAI Stock Symbol:
NASDAQ Market:
predictive-oncology.com Website: